An abstract presented at ACC 2017 explored the cardiovascular effects of cannabis use.
Blood protein analysis of plasma total tau has diagnostic use in Alzheimer disease. Could the same hold true for CTE?
Peter Goadsby, MD discusses the efficacy, safety, & tolerability of the CGRP inhibitor erenumab in a phase III trial of participants with episodic migraine.
Patients with Parkinson disease experiencing “off” episodes on levodopa/carbidopa now have another treatment option.
Did testosterone treatment improve cognitive function and memory in elderly men diagnosed with low testosterone and age-related memory impairment?
Is selective serotonin reuptake inhibitor use associated with an increased risk of spontaneous intracranial hemorrhage?
Is the parkinsonian phenotype seen in welders related to the exposure of manganese-containing welding fumes?
What factors contributed to burnout among your fellow neurologists, and what can you do to reduce your own risk?
Although sauna bathing can be beneficial in cardiovascular disease, how does the practice impact dementia and Alzheimer disease?
Could marijuana use increase the risk of developing Alzheimer disease?